Free Trial

Titan Medical (TMDIF) Competitors

Titan Medical logo
$0.34 0.00 (0.00%)
As of 09/3/2025

TMDIF vs. AVR, PROF, ZJYL, LUCD, RCEL, OBIO, INO, NSPR, HYPR, and SPAI

Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Anteris Technologies Global (AVR), Profound Medical (PROF), Jin Medical International (ZJYL), Lucid Diagnostics (LUCD), Avita Medical (RCEL), Orchestra BioMed (OBIO), Inovio Pharmaceuticals (INO), InspireMD (NSPR), Hyperfine (HYPR), and Safe Pro Group (SPAI). These companies are all part of the "medical equipment" industry.

Titan Medical vs. Its Competitors

Titan Medical (NASDAQ:TMDIF) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

In the previous week, Anteris Technologies Global had 4 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for Anteris Technologies Global and 0 mentions for Titan Medical. Anteris Technologies Global's average media sentiment score of 1.64 beat Titan Medical's score of 0.00 indicating that Anteris Technologies Global is being referred to more favorably in the news media.

Company Overall Sentiment
Titan Medical Neutral
Anteris Technologies Global Very Positive

Anteris Technologies Global has a consensus target price of $16.50, suggesting a potential upside of 313.53%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Anteris Technologies Global
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Titan Medical has higher revenue and earnings than Anteris Technologies Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Titan Medical$17.63M2.18$6.95M$0.056.74
Anteris Technologies Global$2.70M53.29-$76.29MN/AN/A

0.0% of Titan Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 4.0% of Anteris Technologies Global shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Anteris Technologies Global's return on equity of 0.00% beat Titan Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Titan MedicalN/A -82.31% -51.47%
Anteris Technologies Global N/A N/A N/A

Summary

Anteris Technologies Global beats Titan Medical on 9 of the 12 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDIF vs. The Competition

MetricTitan MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$38.45M$81.72M$5.76B$9.85B
Dividend YieldN/AN/A6.71%4.51%
P/E Ratio-0.2711.3659.1122.53
Price / Sales2.1897.89547.00119.09
Price / Cash0.0218.4137.0558.92
Price / Book0.329.1210.916.06
Net Income$6.95M-$26.48M$3.29B$266.28M
7 Day Performance6.77%0.33%0.01%-0.76%
1 Month Performance3.72%8.23%7.06%3.83%
1 Year PerformanceN/A77.81%50.09%24.39%

Titan Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDIF
Titan Medical
N/A$0.34
flat
N/A+811.4%$38.45M$17.63M-0.2750
AVR
Anteris Technologies Global
2.1274 of 5 stars
$3.66
-3.2%
$16.50
+350.8%
N/A$136.32M$2.70M0.00138News Coverage
PROF
Profound Medical
2.3859 of 5 stars
$4.52
+0.2%
$11.00
+143.4%
-49.8%$135.39M$10.68M-3.10150
ZJYL
Jin Medical International
N/A$0.82
-1.3%
N/A-76.3%$129.92M$23.50M0.00245Gap Down
LUCD
Lucid Diagnostics
2.7576 of 5 stars
$1.26
+6.8%
$3.55
+181.7%
+53.1%$128M$4.35M-1.0670High Trading Volume
RCEL
Avita Medical
2.3177 of 5 stars
$4.53
-0.7%
$12.40
+173.7%
-50.1%$121.38M$64.25M-2.30130News Coverage
OBIO
Orchestra BioMed
3.1823 of 5 stars
$2.84
-5.3%
$14.00
+393.0%
-56.6%$115.93M$2.64M-1.554Positive News
Analyst Forecast
INO
Inovio Pharmaceuticals
3.6255 of 5 stars
$2.46
+20.6%
$8.80
+257.7%
-57.9%$108.41M$220K-0.94320High Trading Volume
NSPR
InspireMD
3.5787 of 5 stars
$2.44
-1.2%
$4.50
+84.4%
-10.7%$101.80M$7.07M-3.2550
HYPR
Hyperfine
2.2358 of 5 stars
$1.24
-1.6%
$1.28
+3.5%
+12.6%$99.01M$12.89M-2.38190Gap Down
SPAI
Safe Pro Group
0.4443 of 5 stars
$6.91
+13.1%
$8.00
+15.8%
+58.2%$98.79M$2.17M-8.6411

Related Companies and Tools


This page (NASDAQ:TMDIF) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners